首页> 外文OA文献 >Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities

【2h】

Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities

机译：通过抗血管生成活性组合5-氟尿嘧啶和血管紧张素转化酶抑制剂的组合抑制肝细胞癌生长和肝癌发生的协同抑制作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Koji Yanase; Hitoshi Yoshiji; Yasuhide Ikenaka; Ryuichi Noguchi; Mitsuteru Kitade; Kosuke Kaji; Junichi Yoshii; Tadashi Namisaki; Masaharu Yamazaki; Kiyoshi Asada; Tatsuhiro Tsujimoto; Takemi Akahane; Masahito Uemura; Hiroshi Fukui;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The combination of ulinastatin and 5-fluorouracil synergistically inhibits hepatocellular carcinoma growth [J] . Xueli Hu, Jie Ding, Ge Wang, Journal of International Medical Research . 2020,第3期

机译：UlinaTatin和5-氟尿嘧啶的组合协同抑制肝细胞癌生长
2. Combination of branched-chain amino acids and angiotensin-converting enzyme inhibitor suppresses the cumulative recurrence of hepatocellular carcinoma: a randomized control trial. [J] . Yoshiji H, Noguchi R, Ikenaka Y, Oncology reports . 2011,第6期

机译：支链氨基酸和血管紧张素转化酶抑制剂的组合可抑制肝细胞癌的累积复发：一项随机对照试验。
3. Combination of vitamin K2 and angiotensin-converting enzyme inhibitor ameliorates cumulative recurrence of hepatocellular carcinoma. [J] . Yoshiji H, Noguchi R, Toyohara M Journal of Hepatology: The Journal of the European Association for the Study of the Liver . 2009,第2期

机译：维生素K2和血管紧张素转换酶抑制剂的组合可改善肝细胞癌的累积复发。
4. Aquaporin-1 Deletion in Mice Inhibits Hepa1-6 Hepatocellular Carcinoma Growth [C] . Yong Jiang, Xin Zhang, Kun Chen, Bioinformatics and Biomedical Engineering , 2009. ICBBE 2009 . 2009

机译：小鼠中水通道蛋白1缺失抑制Hepa1-6肝细胞癌的生长
5. The anti-cancer activities of Paeoniae Radix extracts on human hepatocellular carcinoma cell-line HepG2 and multidrug resistant human hepatocellular carcinoma cell-line R-HepG2 and their action mechanisms. [D] . Li, Lok Yee Mandy. 2004

机译：e药提取物对人肝癌细胞HepG2和多药耐药人肝癌细胞R-HepG2的抗癌活性及其作用机制。
6. The combination of ulinastatin and 5-fluorouracil synergistically inhibits hepatocellular carcinoma growth [O] . Xueli Hu, Jie Ding, Ge Wang, 2020

机译：乌司他丁和5-氟尿嘧啶的组合协同抑制肝细胞癌的生长
7. The combination of ulinastatin and 5-fluorouracil synergistically inhibits hepatocellular carcinoma growth [O] . Xueli Hu, Jie Ding, Ge Wang, 2020

机译：UlinaTatin和5-氟尿嘧啶的组合协同抑制肝细胞癌生长

Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities

著录项

引文网络

相似文献

相关主题

期刊订阅